Literature DB >> 27408394

Blood Group Discrepancy-First Sign of Autoimmune Hemolytic Anemia after Hematopoietic Stem Cell Transplantation in a Child.

Suvro Sankha Datta1, Mahua Reddy2, Sabita Basu2, Shekhar Krishnan3.   

Abstract

A 12-year-old male child was presented in the emergency with features of anemia and mild icterus on day+67 of HSCT. The child was suffering from Fanconi anemia and undergone HSCT from ABO-matched, fully HLA matched sibling donor. The diagnosis of mixed type AIHA due to cytomegalovirus reactivation was made in the immunohematology laboratory and blood group discrepancy was the first sign of AIHA in this patient. Though the cold agglutinin titer was not significant but the clinical symptoms and laboratory evidences were suggestive of significant hemolysis due to underlying IgG autoantibody. In addition the high complement avidity of IgM autoantibody might also be a contributing factor for clinically significant hemolysis in this case. The patient was successfully treated with phenotype matched blood transfusion, rituximab and oral steroid therapy.

Entities:  

Keywords:  Autoantibody; Hematopoietic stem cell transplantation; Phenotype matching

Year:  2015        PMID: 27408394      PMCID: PMC4925543          DOI: 10.1007/s12288-015-0630-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  9 in total

1.  Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital.

Authors:  Meng Wang; Wenjia Wang; Ayesha Abeywardane; Malinthi Adikarama; Donal McLornan; Kavita Raj; Hugues de Lavallade; Stephen Devereux; Ghulam J Mufti; Antonio Pagliuca; Victoria T Potter; Aleksandar Mijovic
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-28       Impact factor: 5.742

Review 2.  Immune hemolysis associated with transplantation.

Authors:  Lawrence D Petz
Journal:  Semin Hematol       Date:  2005-07       Impact factor: 3.851

3.  Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation.

Authors:  B Horn; M Viele; W Mentzer; N Mogck; K DeSantes; M Cowan
Journal:  Bone Marrow Transplant       Date:  1999-11       Impact factor: 5.483

4.  The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.

Authors:  Ibrahim Ahmed; Jun Teruya; Cristina Murray-Krezan; Robert Krance
Journal:  Pediatr Transplant       Date:  2015-03-23

Review 5.  Autoimmune diseases and autoimmunity post-bone marrow transplantation.

Authors:  Y Sherer; Y Shoenfeld
Journal:  Bone Marrow Transplant       Date:  1998-11       Impact factor: 5.483

6.  Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases.

Authors:  Tracey A O'Brien; Ted Eastlund; Charles Peters; Joseph P Neglia; Todd Defor; Norma K C Ramsay; K Scott Baker
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

7.  Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease.

Authors:  Ashok Raj; Salvatore Bertolone; Alexandra Cheerva
Journal:  J Pediatr Hematol Oncol       Date:  2004-05       Impact factor: 1.289

Review 8.  Autoimmunity following haematopoietic stem-cell transplantation.

Authors:  Thomas Daikeler; Alan Tyndall
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

9.  Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience.

Authors:  Maura Faraci; Marco Zecca; Marta Pillon; Attilio Rovelli; Maria Cristina Menconi; Mimmo Ripaldi; Franca Fagioli; Marco Rabusin; Ottavio Ziino; Edoardo Lanino; Franco Locatelli; Thomas Daikeler; Arcangelo Prete
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-23       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.